ロード中...
A Case Report with Severe Thrombocytopenia Induced by Axitinib
Axitinib is an oral, second-generation tyrosine kinase inhibitor that is selective for vascular endothelial growth factor receptors (VEGFR). This agent is approved as monotherapy or in combination with immune checkpoint inhibitors for the treatment of metastatic renal cell carcinoma. Axitinib is ass...
保存先:
| 出版年: | Case Rep Hematol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7029294/ https://ncbi.nlm.nih.gov/pubmed/32089908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7520783 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|